Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : WPI Watson Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: chengchung chang who wrote (39)	4/6/1999 7:09:00 PM
From: Zebra 365	Read Replies (2) \| Respond to of 61

Recalls are just rumor. S&P 500 is a fact. Now WPI is a "Must Buy" for S&P 500 Index funds. NEW YORK--(BUSINESS WIRE)--April 6, 1999--Standard & Poor's Financial Information Services will make the following changes in the S&P 500 and S&P MidCap 400 after the close of trading on Friday, April 9, 1999. S&P MidCap 400 component Watson Pharmaceuticals (WPI) will replace Aeroquip-Vickers Inc. (ANV) in the S&P 500 Index. Watson Pharmaceuticals is engaged in the development, manufacture and sale of proprietary and off-patent pharmaceutical products. The company, headquartered in Corona, California, will be added to the S&P 500 Health Care (Drugs-Generic & Other) industry group. Zebra

To: chengchung chang who wrote (39)	4/8/1999 1:52:00 PM
From: Selk	Read Replies (2) \| Respond to of 61

The recall information that I reported came from an individual that I work with whose family has had Watson in their portfolio for many years. Over the years of holding this stock, they were very pleased with its rise in price, but when it took its sudden sharp dive, they called their money manager to find out why. Apparently, there were "black specks" in a product...don't know which one...and it was recalled. As you may know, the pharmaceutical industry is EXTREMELY regulated both internally by the companies themselves and the FDA to ensure product quality and purity. The company I work for goes through incredible quality assurance steps throughout its manufacturing processes. At times, although very rare, it is possible for contamination to occur. The VAST majority of the companies in this industry will make a recall themselves if they determine a problem exists and notify the FDA immediately. A single recall does not mean that things are cratering at the company, however, if the frequency of recalls increases, it might. IMHO I do not see that at Watson. At this time, I do not hold any Watson stock, but was looking at it when it was going down, hoping for an entry point at 35 or lower to add it to my IRA for the long term. Its a good company with a future. Selk